{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T17:14:45Z","timestamp":1777828485966,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Italian Ministry of University and Research"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejps.2015.04.022","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T01:17:25Z","timestamp":1430183845000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes"],"prefix":"10.1016","volume":"74","author":[{"given":"Marcella","family":"Manerba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Di Ianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Fiume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinella","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Recanatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.04.022_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2049-3002-1-19","article-title":"Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells","volume":"1","author":"Billiard","year":"2013","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.ejps.2015.04.022_b0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jcp.2007.047977","article-title":"Epstein\u2013Barr virus and Burkitt lymphoma","volume":"84","author":"Brady","year":"2008","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejps.2015.04.022_b0015","doi-asserted-by":"crossref","unstructured":"Breitinger, H.G., 2012. Drug Synergy \u2013 Mechanisms and Methods of Analysis. In: Acree, B., editor: Toxicity and Drug Testing, InTech. ISBN: 978-953-51-0004-1, http:\/\/dx.doi.org\/10.5772\/30922. <http:\/\/www.intechopen.com\/books\/toxicity-and-drug-testing\/drug-synergy-mechanisms-and-methods-of-analysis>.","DOI":"10.5772\/30922"},{"key":"10.1016\/j.ejps.2015.04.022_b0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","article-title":"Oxidative DNA damage: mechanisms, mutation, and disease","volume":"17","author":"Cooke","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2015.04.022_b0025","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1021\/jp3116319","article-title":"Free radical scavenging by natural polyphenols: atom versus electron transfer","volume":"117","author":"Di Meo","year":"2013","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ejps.2015.04.022_b0030","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.2174\/15680266113136660207","article-title":"NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases","volume":"13","author":"Di Stefano","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejps.2015.04.022_b0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.tips.2006.04.007","article-title":"Emerging cancer therapeutic opportunities target DNA-repair systems","volume":"27","author":"Ding","year":"2006","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.04.022_b0040","first-page":"443","article-title":"Energetic characteristics of cisplatin resistant ovarian carcinoma cells","volume":"16","author":"Dorward","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejps.2015.04.022_b0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00432-011-1093-y","article-title":"Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt\u2019s lymphoma cells","volume":"138","author":"Dos Santos Ferreira","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejps.2015.04.022_b0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ejps.2012.08.012","article-title":"Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways","volume":"47","author":"Farabegoli","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.04.022_b0055","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1016\/j.bmcl.2014.10.067","article-title":"Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase","volume":"24","author":"Fauber","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2015.04.022_b0060","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1517\/14728222.2014.925617","article-title":"Comment on: targeting homologous recombination-mediated DNA repair in cancer","volume":"18","author":"Fiume","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejps.2015.04.022_b0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4155\/fmc.13.206","article-title":"Inhibition of lactate dehydrogenase activity as an approach to cancer therapy","volume":"6","author":"Fiume","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejps.2015.04.022_b0070","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/cancers6041821","article-title":"Positron emission tomography (PET) in oncology","volume":"6","author":"Gallamini","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2015.04.022_b0075","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.2967\/jnumed.107.047258","article-title":"Causes and consequences of increased glucose metabolism of cancers","volume":"49","author":"Gillies","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejps.2015.04.022_b0080","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2174\/092986710790416263","article-title":"Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials","volume":"17","author":"Granchi","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2015.04.022_b0085","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.23525","article-title":"Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir","volume":"123","author":"Hernlund","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2015.04.022_b0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molonc.2008.01.003","article-title":"3-Bromopyruvate as inhibitor of tumor cell energy metabolism and chemopotentiator of platinum drugs","volume":"2","author":"Ihrlund","year":"2008","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejps.2015.04.022_b0095","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2015.04.022_b0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-8981(88)90359-2","article-title":"Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy","volume":"173","author":"Kanno","year":"1988","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2015.04.022_b0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","article-title":"Mechanisms of resistance to cisplatin","volume":"478","author":"Kartalou","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejps.2015.04.022_b0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.dnarep.2007.12.008","article-title":"The consequences of Rad51 overexpression for normal and tumor cells","volume":"7","author":"Klein","year":"2008","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejps.2015.04.022_b0115","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2015.04.022_b0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2014.00221","article-title":"Hormone resistance in two MCF-7 breast cancer cell lines is associated with reduced mTOR signaling, decreased glycolysis, and increased sensitivity to cytotoxic drugs","volume":"4","author":"Leung","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2015.04.022_b0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1538-7445.PRCA2012-A4","article-title":"Inhibitors of DNA repair for cancer therapy, ready for prime time?","volume":"1","author":"Li","year":"2012","journal-title":"Trans. Cancer Res."},{"key":"10.1016\/j.ejps.2015.04.022_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.10.883","article-title":"Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells","volume":"202","author":"Loar","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejps.2015.04.022_b0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejps.2015.04.022_b0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2015.04.022_b0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0006-291X(90)92374-9","article-title":"Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency","volume":"168","author":"Maekawa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2015.04.022_b0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cmdc.201100471","article-title":"Galloflavin (CAS 568\u201380-9): a novel inhibitor of lactate dehydrogenase","volume":"7","author":"Manerba","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejps.2015.04.022_b0155","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/JVI.66.8.4972-4981.1992","article-title":"Epstein\u2013Barr Virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants","volume":"66","author":"Marchini","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2015.04.022_b0160","doi-asserted-by":"crossref","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.ejps.2015.04.022_b0165","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1212\/WNL.43.7.1414","article-title":"Molecular characterization of gene expression in human lactate dehydrogenase-A deficiency","volume":"43","author":"Miyajima","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2015.04.022_b0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.lungcan.2013.01.014","article-title":"PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs","volume":"80","author":"Olaussen","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejps.2015.04.022_b0175","first-page":"278","article-title":"The role of glycolysis in the growth of tumor cells. I. Effects of oxamic acid on the metabolism of Ehrlich tumor cells in vitro","volume":"236","author":"Papacostantinou","year":"1961","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2015.04.022_b0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/978-1-61779-998-3_40","article-title":"Histone H2AX phosphorylation: a marker for DNA damage","volume":"920","author":"Sharma","year":"2012","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.ejps.2015.04.022_b0185","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1073\/pnas.94.13.6658","article-title":"C-Myc transactivation of LDH-A: implications for tumor metabolism and growth","volume":"94","author":"Shim","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejps.2015.04.022_b0190","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1007\/s13277-014-1902-4","article-title":"Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin","volume":"35","author":"Song","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ejps.2015.04.022_b0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00280-013-2366-8","article-title":"Targeting cisplatin-resistant human tumor cells with metabolic inhibitors","volume":"73","author":"Sullivan","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2015.04.022_b0200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bbagrm.2014.02.013","article-title":"Chromatin dynamics: interplay between remodeling enzymes and histone modifications","volume":"1839","author":"Swygert","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2015.04.022_b0205","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2015.04.022_b0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ana.410360418","article-title":"Molecular genetic studies of muscle lactate dehydrogenase deficiency in white patients","volume":"36","author":"Tsujno","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2015.04.022_b0215","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/CAD.0b013e328363ae50","article-title":"Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD\/NADH-dependent inhibition of sirtuin-1","volume":"24","author":"Vettraino","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ejps.2015.04.022_b0220","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1021\/jm201734r","article-title":"Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation","volume":"55","author":"Ward","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2015.04.022_b0225","first-page":"409","article-title":"Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells","volume":"38","author":"Xie","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejps.2015.04.022_b0230","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","article-title":"Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells","volume":"19","author":"Xie","year":"2014","journal-title":"Cell Metabol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejps.2015.04.022_b0235","first-page":"S41","article-title":"Chemosensitizing and cytotoxic effects of 2-deoxy-d-glucose on breast cancer cells","volume":"5","author":"Zhang","year":"2009","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ejps.2015.04.022_b0240","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/leu.2013.94","article-title":"Disruption of MYC-MiRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity","volume":"27","author":"Zhao","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejps.2015.04.022_b0245","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1007\/s13277-014-2543-3","article-title":"Overcoming 5-Fu resistance in human non-small cell lung cancer cells by the combination of 5-Fu and cisplatin through the inhibition of glucose metabolism","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumour Biol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098715001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:50:41Z","timestamp":1598961041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098715001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":49,"alternative-id":["S0928098715001773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.04.022","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}